Robert B. Bazemore, President & CEO at Epizyme, Inc. (EPZM), sold 20,656 shares at $7.85 ($162K) on 2021-03-25, disclosed to the SEC on 2021-03-29.
Open-market sale of $162k EPZM by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.85 | 10,328 | $81K | 50.0% |
| 2 | $7.85 | 10,328 | $81K | 50.0% |
| Total | $7.85 avg | 20,656 | $162K | 100% |
| Filing → |
| EPZM | SELL | 2021-01-27 | $138K | — | Filing → |
| EPZM | SELL | 2020-06-30 | $154K | — | Filing → |
| EPZM | SELL | 2020-06-22 | $220K | — | Filing → |